Clinical Trials Browser

Phase 3 × Alzheimer Disease × Rosiglitazone × Clear all

NCT00428090 2017-05-19

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

Phase 3 Completed

862 enrolled 36 charts

Alzheimer Disease, Lymphoma, Follicular